• About us
• Contact

Advertisement

Organisation › Details

Genomics England Ltd.

Genomics England (www.genomicsengland.co.uk) was incorporated on 17 April 2013 as a company to take forward the Prime Minister's 100,000 Genome Project. The Project will introduce high-tech DNA mapping for rare diseases patients and those with cancer or infectious diseases and link that new data to the patient's medical records. This will give doctors a new advanced understanding of a patient's genetic make-up, condition, and treatment needs, ensuring they have access to the right drugs and personalised care far quicker than ever before. Genomics England Limited is owned by the UK Department of Health. *

 

	Start	2013-04-17 established
	Group	United Kingdom (GB) (govt)
	Industry	genome sequencing
	Industry 2	genomics
	Person	Caulfield, Mark (Genomics England 201901– interim Chief Executive)
	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	Charterhouse Square Dawson Hall
	City	EC1M 6BQ London
	Tel	+44-207-882-6392
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2025-05-11

Advertisement

More documents for United Kingdom (GB) (govt)

• [1] NICE (National Institute for Health and Care Excellence). (6/19/25). "Press Release: Final Draft Guidance Finds Benefits of 2 Alzheimer’s Treatments Remain too Small to Justify the Additional Cost to the NHS"....
• [2] BioNTech SE. (5/20/25). "Press Release: BioNTech Expands Partnership with UK Government to Broaden Regional Research and Development Activities". Mainz....
• [3] British Business Bank plc. (3/21/25). "Press Release: British Business Bank Commits up to £30m to Thena Capital’s Inaugural UK MedTech Fund"....
• [4] Qiagen N.V.. (1/7/25). "Press Release: Qiagen Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content". Redwood City, CA & Venlo....
• [5] Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA....
• [6] ERS Genomics Ltd.. (9/4/24). "Press Release: ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement". Dublin & Cheshire....
• [7] BoobyBiome Ltd.. (8/22/24). "Press Release: BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research". London....
• [8] Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham....
• [9] Good Dog Food Ltd. (d/b/a Meatly). (7/10/24). "Press Release: World-First Regulatory Approval. Meatly Becomes First Ever European Company Authorised to Sell Cultivated Meat, Following UK Clearance for Its Cultivated Pet Food"....
• [10] Cellular Origins Ltd.. (5/29/24). "Press Release: Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing". Cambridge & Stevenage....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.